Bavarian Nordic scoops FDA approval for chikungunya vaccine in adults and teens

Bavarian Nordic has won US Food and Drug Administration (FDA) approval for its chikungunya vaccine Vimkunya, becoming the second company in the US to market a vaccine for the tropical disease.